SCHEMBL7172185

SCHEMBL7172185

CCCCOc1ccc(NC(C(=O)NC(C(=O)NC)C(C)(C)C)C(O)C(=O)NO)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 16/20 0.55
MMP1 P03956 14/20 0.55
MMP9 P14780 3/20 0.55
FCER2 P06734 1/20 0.46
PPARG P37231 1/20 0.46
MMP2 P08253 5/20 0.46
MMP7 P09237 2/20 0.46
MMP8 P22894 2/20 0.46
TNF P01375 2/20 0.46
MMP13 P45452 2/20 0.46
ADAM17 P78536 2/20 0.46
MMP20 O60882 1/20 0.46
ADAMTS4 O75173 1/20 0.46
MMP10 P09238 1/20 0.46
MMP12 P39900 1/20 0.46
MMP14 P50281 1/20 0.46
MMP15 P51511 1/20 0.46
MMP16 P51512 1/20 0.46
MMP25 Q9NPA2 1/20 0.46
MMP26 Q9NRE1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177123 0.97 MMP3 (0.57) MMP3MMP1MMP9FCER2PPARG
SCHEMBL7172616 0.91 MMP3 (0.46) MMP3MMP1MMP9FCER2PPARG
SCHEMBL7174311 0.88 MMP3 (0.48) MMP3MMP1MMP9PPARG
SCHEMBL7170041 0.86 MMP3 (0.52) MMP3MMP1MMP9FCER2PPARG
SCHEMBL7172650 0.85 NPC1 (0.47) MMP3MMP1MMP9PPARG
SCHEMBL7177702 0.84 MMP3 (0.50) MMP3MMP1MMP9PPARGMMP2
SCHEMBL7178370 0.83 PPARG (0.46) MMP3MMP1MMP9PPARG
SCHEMBL7170096 0.83 FCER2 (0.50) MMP3MMP1MMP9FCER2MMP2
SCHEMBL7172189 0.81 PPARG (0.44) MMP3MMP1MMP9PPARGMMP2
SCHEMBL7177453 0.80 MMP3 (0.55) MMP3MMP1MMP9FCER2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576628-B1 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis ROCHE DIAGNOSTICS GMBH (DE) 2003-06-10 US disclosed
EP-1005449-B1 3-ARYL-SUCCINAMIDO-HYDROXAMIC ACIDS, METHODS FOR PRODUCING SAID ACIDS AND MEDICAMENTS CONTAINING THE SAME ROCHE DIAGNOSTICS GMBH (DE) 2002-10-30 EP disclosed
EP-0897908-A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1999-02-24 EP disclosed